# Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)

> **NCT02959762** · NA · UNKNOWN · sponsor: **Augusta University** · enrollment: 30 (estimated)

## Conditions studied

- Obesity
- Insulin Resistance
- Obesity in Diabetes
- Nutritional and Metabolic Diseases
- Hyperlipidemia
- Hyperglycemia
- Cardiovascular Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo-Control
- **DIETARY_SUPPLEMENT:** Low-Dose Vitamin K2 (menaquinone-7; 45-mcg/d)
- **DIETARY_SUPPLEMENT:** High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)

## Key facts

- **NCT ID:** NCT02959762
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02959762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02959762, "Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02959762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*